The non-psychedelic compound known as 18-Methoxycoronaridine (18-MC) has become a recurring character in iboga like alkaloid research, as its unique effects trail the resurgence of psychedelic research.1 18-MC mirrors the anti-addiction properties of ibogaine, interrupting a person’s dependence on stimulants, opiates, alcohol, and nicotine. As a promising compound, it has caught the eye of many…
